Reckitt, baby formula

Reckitt still assessing options for Mead Johnson infant-formula “exit”
CEO Kris Licht said last week that Reckitt has received “interest” from prospective buyers for its nutrition unit housing Mead Johnson.
Reckitt says US court grants new trial in premature-infant formula case
Reckitt said on Friday a U.S. circuit court has ruled that a new trial could be sought by plaintiffs in a case that had accused the London-listed firm and Abbott of failing to warn of the risks of premature baby formulas.
That baby formula trial Abbott and Reckitt won isn't over just yet
Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a baby developing necrotizing enterocolitis, or NEC, from their cow-milk-based formulas. NEC is a serious, and sometimes deadly, gastrointestinal disease that primarily afflicts premature infants.
Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial
Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.
‘A Manifest Injustice': Judge Who Sanctioned Abbott’s Counsel Grants New Infant Formula Trial
Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing the “widespread misconduct” of defendants Abbott Laboratories Inc. and Mead Johnson.
Reckitt Shares Drop on Infant Formula Retrial in U.S.
Reckitt--which houses Dettol, Harpic and Durex among its brands--said the judge ordered a retrial of a Missouri lawsuit that had found in October that subsidiary Mead Johnson wasn't liable for injuries suffered by a child who consumed its formula designed for premature babies.
Abbott and Reckitt Fall on News of New Infant Formula Trial
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants,
Reuters9d
Strepsils maker Reckitt misses sales forecast on late flu season, but lower costs help
Reckitt has had a mixed year, with its stock falling sharply early on in 2024 over an internal investigation into its ...
Citi sees overturned verdict in state case as incrementally negative for Abbott
Citi notes that Investing.com reported on Friday that the judge in the Whitfield infant formula case has overturned the October 31 verdict, ...
Reckitt slumps on renewed litigation uncertainty - RBC Capital Markets
In March 2024, a U.S. court in Illinois awarded $60 million in damages to a mother of a baby that died from necrotizing ...
Consumer good giants Reckitt 'evaluating opportunities' for controversial baby formula brand Mead Johnson
Reckitt and rival Abbott Laboratories are defending more than 1,000 lawsuits alleging a connection between their milk-based ...
Reckitt Benckiser sees sales and profits fall amid turnaround
Reckitt Benckiser's shares hit an 11-year low in July but a turnaround strategy in the summer has seen it regain momentum ...